Haemonetics (HAE) Revenue & Revenue Breakdown
Haemonetics Revenue Highlights
Latest Revenue (Y)
$1.31B
Latest Revenue (Q)
$336.17M
Main Segment (Y)
Service
Main Geography (Y)
UNITED STATES
Haemonetics Revenue by Period
Haemonetics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-03-30 | $1.31B | 12.01% |
| 2023-04-01 | $1.17B | 17.67% |
| 2022-04-02 | $993.20M | 14.10% |
| 2021-04-03 | $870.46M | -11.94% |
| 2020-03-28 | $988.48M | 2.16% |
| 2019-03-30 | $967.58M | 7.04% |
| 2018-03-31 | $903.92M | 2.01% |
| 2017-04-01 | $886.12M | -2.59% |
| 2016-04-02 | $909.67M | -0.08% |
| 2015-03-28 | $910.37M | -3.00% |
| 2014-03-29 | $938.51M | 5.22% |
| 2013-03-30 | $891.99M | 22.55% |
| 2012-03-31 | $727.84M | 7.56% |
| 2011-04-02 | $676.69M | 4.84% |
| 2010-04-03 | $645.43M | 7.95% |
| 2009-03-28 | $597.88M | 15.77% |
| 2008-03-29 | $516.44M | 14.86% |
| 2007-03-31 | $449.61M | 7.12% |
| 2006-04-01 | $419.73M | 9.42% |
| 2005-04-02 | $383.60M | 5.32% |
| 2004-04-03 | $364.23M | 8.09% |
| 2003-03-29 | $336.96M | 5.31% |
| 2002-03-30 | $319.97M | 8.88% |
| 2001-03-31 | $293.86M | 5.73% |
| 2000-04-01 | $277.92M | -1.48% |
| 1999-04-03 | $282.10M | -1.29% |
| 1998-03-28 | $285.80M | -7.75% |
| 1997-03-29 | $309.80M | 11.36% |
| 1996-03-30 | $278.20M | 6.02% |
| 1995-03-31 | $262.40M | 5.64% |
| 1994-03-31 | $248.40M | - |
Haemonetics generated $1.31B in revenue during NA 2024, up 12.01% compared to the previous quarter, and up 135.29% compared to the same period a year ago.
Haemonetics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-29 | $336.17M | -2.07% |
| 2024-03-30 | $343.29M | 2.09% |
| 2023-12-30 | $336.25M | 5.68% |
| 2023-09-30 | $318.18M | 2.20% |
| 2023-07-01 | $311.33M | 2.27% |
| 2023-04-01 | $304.42M | -0.29% |
| 2022-12-31 | $305.30M | 2.63% |
| 2022-10-01 | $297.49M | 13.78% |
| 2022-07-02 | $261.46M | -1.34% |
| 2022-04-02 | $265.00M | 2.01% |
| 2022-01-01 | $259.77M | 8.28% |
| 2021-10-02 | $239.90M | 4.97% |
| 2021-07-03 | $228.53M | 1.55% |
| 2021-04-03 | $225.03M | -6.38% |
| 2020-12-26 | $240.37M | 14.74% |
| 2020-09-26 | $209.49M | 7.11% |
| 2020-06-27 | $195.58M | -17.99% |
| 2020-03-28 | $238.49M | -7.91% |
| 2019-12-28 | $258.97M | 2.54% |
| 2019-09-28 | $252.57M | 5.92% |
| 2019-06-29 | $238.45M | -4.35% |
| 2019-03-30 | $249.29M | 0.78% |
| 2018-12-29 | $247.36M | 2.39% |
| 2018-09-29 | $241.58M | 5.33% |
| 2018-06-30 | $229.35M | -1.80% |
| 2018-03-31 | $233.55M | -0.21% |
| 2017-12-30 | $234.04M | 3.85% |
| 2017-09-30 | $225.38M | 6.84% |
| 2017-07-01 | $210.95M | -7.50% |
| 2017-04-01 | $228.07M | 0.10% |
| 2016-12-31 | $227.84M | 3.45% |
| 2016-10-01 | $220.25M | 4.90% |
| 2016-07-02 | $209.96M | -13.66% |
| 2016-04-02 | $243.19M | 4.20% |
| 2015-12-26 | $233.38M | 6.23% |
| 2015-09-26 | $219.69M | 2.94% |
| 2015-06-27 | $213.41M | -5.77% |
| 2015-03-28 | $226.48M | -2.31% |
| 2014-12-27 | $231.83M | 1.87% |
| 2014-09-27 | $227.58M | 1.38% |
| 2014-06-28 | $224.49M | -6.89% |
| 2014-03-29 | $241.09M | -0.42% |
| 2013-12-28 | $242.12M | 2.70% |
| 2013-09-28 | $235.75M | 7.38% |
| 2013-06-29 | $219.54M | -12.16% |
| 2013-03-30 | $249.94M | 1.03% |
| 2012-12-29 | $247.40M | 13.39% |
| 2012-09-29 | $218.18M | 23.63% |
| 2012-06-30 | $176.47M | -5.46% |
| 2012-03-31 | $186.67M | -2.35% |
| 2011-12-31 | $191.16M | 6.53% |
| 2011-10-01 | $179.44M | 5.20% |
| 2011-07-02 | $170.57M | 0.32% |
| 2011-04-02 | $170.03M | -3.82% |
| 2011-01-01 | $176.79M | 5.97% |
| 2010-10-02 | $166.83M | 2.33% |
| 2010-07-03 | $163.04M | -3.59% |
| 2010-04-03 | $169.10M | 2.38% |
| 2009-12-26 | $165.17M | 5.16% |
| 2009-09-26 | $157.07M | 1.94% |
| 2009-06-27 | $154.09M | 1.11% |
| 2009-03-28 | $152.40M | -1.96% |
| 2008-12-27 | $155.45M | 6.53% |
| 2008-09-27 | $145.92M | 1.25% |
| 2008-06-28 | $144.12M | 3.88% |
| 2008-03-29 | $138.74M | - |
Haemonetics generated $336.17M in revenue during Q1 2025, up -2.07% compared to the previous quarter, and up 110.43% compared to the same period a year ago.
Haemonetics Revenue Breakdown
Haemonetics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Mar 24 | Apr 23 | Apr 22 | Apr 21 | Mar 20 |
|---|---|---|---|---|---|
| Service | $21.63M | $21.42M | $20.81M | $20.76M | $19.83M |
| Hospital | - | $378.11M | $329.43M | $216.58M | $198.42M |
| Blood Center | - | $226.82M | $236.16M | $239.61M | $252.83M |
| Plasma | - | $563.73M | $427.61M | $414.27M | $537.23M |
Haemonetics's latest annual revenue breakdown by segment (product or service), as of Mar 24: Service (100.00%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jul 23 | Dec 22 | Oct 22 | Jul 22 | Jan 22 | Oct 21 | Jul 21 | Apr 21 | Dec 20 | Sep 20 | Jun 20 | Dec 19 | Sep 19 | Jun 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Service | $5.23M | $5.59M | $5.04M | $5.77M | $5.37M | $5.41M | $5.14M | $5.44M | $4.95M | $5.27M | $4.97M | $5.34M | $5.08M | $5.20M | $5.28M | $4.87M | - | - | - | - |
| Blood Center Products and Services | - | - | - | - | $58.27M | $61.90M | $52.92M | $59.44M | $59.93M | $57.75M | $62.79M | $59.23M | $60.67M | $66.13M | $65.61M | $59.91M | - | - | - | - |
| Hospital Products and Services | - | - | - | - | $93.13M | $92.43M | $90.19M | $83.98M | $77.89M | $80.27M | $54.07M | $52.54M | $46.20M | $51.61M | $51.10M | $48.80M | - | - | - | - |
| Plasma Products and Services | - | - | - | - | $153.90M | $143.16M | $118.35M | $116.35M | $102.08M | $90.51M | $123.51M | $97.71M | $88.71M | $141.23M | $135.85M | $129.75M | - | - | - | - |
| Blood Center | - | - | - | - | - | - | - | - | - | - | $72.92M | $67.16M | $68.24M | $64.48M | - | - | - | - | - | - |
| Plasma | - | - | - | - | - | - | - | - | - | - | $83.75M | $131.82M | $124.35M | $116.90M | - | - | - | - | - | - |
| Hospital | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $48.38M | $48.99M | $47.96M |
Haemonetics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Service (100.00%).
Haemonetics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Mar 24 | Apr 23 | Apr 22 | Apr 21 | Mar 20 |
|---|---|---|---|---|---|
| Asia | $107.54M | $104.14M | $110.80M | $105.82M | $109.30M |
| Europe | $160.14M | $156.68M | $163.52M | $159.08M | $153.35M |
| JAPAN | $58.09M | $61.30M | $75.56M | $77.68M | $72.22M |
| Other Country or Region | $13.28M | $3.65M | $3.99M | $5.28M | $7.42M |
| UNITED STATES | $970.01M | $842.90M | $639.32M | $522.61M | $646.20M |
| Blood Center | - | - | $236.16M | - | - |
| Service | - | - | $20.81M | - | - |
| Plasma | - | - | $427.61M | - | - |
| Hospital | - | - | $329.43M | - | - |
Haemonetics's latest annual revenue breakdown by geography, as of Mar 24: UNITED STATES (74.10%), Europe (12.23%), Asia (8.21%), JAPAN (4.44%), and Other Country or Region (1.01%).
Quarterly Revenue by Country
| Country | Mar 24 | Dec 23 | Sep 23 | Jul 23 | Dec 22 | Oct 22 | Jul 22 | Jan 22 | Oct 21 | Jul 21 | Dec 20 | Sep 20 | Jun 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asia | $26.83M | $30.93M | $27.73M | $22.04M | $25.45M | $27.86M | $24.42M | $30.43M | $26.77M | $25.95M | $29.05M | $26.17M | $22.38M | $29.44M | $30.19M | $28.64M | $29.17M | $30.57M | $29.39M | - |
| Europe | $45.05M | $37.03M | $38.67M | $39.39M | $39.10M | $41.85M | $40.46M | $41.54M | $41.18M | $43.34M | $41.87M | $38.65M | $43.02M | $40.98M | $38.07M | $36.75M | $40.98M | $39.10M | $39.00M | - |
| JAPAN | $16.48M | $14.82M | $15.01M | $11.77M | $15.55M | $15.13M | $13.88M | $19.92M | $18.81M | $17.22M | $20.85M | $19.64M | $16.83M | $19.27M | $20.38M | $15.47M | $17.98M | $17.73M | $17.17M | $17.39M |
| Other Country or Region | $9.15M | $2.65M | $426.00K | $1.06M | $1.09M | $921.00K | $703.00K | $609.00K | $1.03M | $992.00K | $986.00K | $1.04M | $2.33M | $2.04M | $2.04M | $1.22M | $2.02M | $1.81M | $1.42M | - |
| UNITED STATES | $245.78M | $250.80M | $236.34M | $237.07M | $224.10M | $211.72M | $182.00M | $167.27M | $152.11M | $141.03M | $147.61M | $123.98M | $111.01M | $167.24M | $161.88M | $156.38M | $157.46M | $152.93M | $142.14M | - |
| North America Plasma | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $100.53M | - | - | - |
| EMEA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $46.47M | - | - | - |
| Americas Blood Center and Hospital and Asia - Pacific | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $86.48M | - | - | - |
Haemonetics's latest quarterly revenue breakdown by geography, as of Mar 24: UNITED STATES (71.60%), Europe (13.12%), Asia (7.81%), JAPAN (4.80%), and Other Country or Region (2.66%).
Haemonetics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ALC | Alcon | $10.09B | $2.46B |
| RMD | ResMed | $4.69B | $1.22B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $909.29M |
| TFX | Teleflex | $2.97B | $764.38M |
| WST | West Pharmaceutical Services | $2.95B | $746.90M |
| NVST | Envista | $2.57B | $884.70M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $339.85M |
| ATRC | AtriCure | $399.25M | $115.91M |
| ANGO | AngioDynamics | $303.91M | $67.49M |
| AKYA | Akoya Biosciences | $96.63M | $23.16M |
| ATRI | Atrion | - | $48.77M |
HAE Revenue FAQ
What is Haemonetics’s yearly revenue?
Haemonetics's yearly revenue for 2024 was $1.31B, representing an increase of 12.01% compared to 2023. The company's yearly revenue for 2023 was $1.17B, representing an increase of 17.67% compared to 2022. HAE's yearly revenue for 2022 was $993.2M, representing an increase of 14.10% compared to 2021.
What is Haemonetics’s quarterly revenue?
Haemonetics's quarterly revenue for Q1 2025 was $336.17M, a -2.07% decrease from the previous quarter (Q4 2024), and a 7.98% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $343.29M, a 2.09% increase from the previous quarter (Q3 2024), and a 12.77% increase year-over-year (Q4 2023). HAE's quarterly revenue for Q3 2024 was $336.25M, a 5.68% increase from the previous quarter (Q2 2024), and a 10.14% increase year-over-year (Q3 2023).
What is Haemonetics’s revenue growth rate?
Haemonetics's revenue growth rate for the last 3 years (2022-2024) was 31.80%, and for the last 5 years (2020-2024) was 32.43%.
What are Haemonetics’s revenue streams?
Haemonetics's revenue streams in r 24 are Service
What is Haemonetics’s main source of revenue?
For the fiscal year ending Mar 24, the largest source of revenue of Haemonetics was Service. This segment made a revenue of $21.63M, representing 100.00% of the company's total revenue.